Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06946914 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Misoprostol Before Caesarean Section

Study acronym: Miso/CS
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 13, 2025 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase: Not applicable to Phase 4v3
  2. Phase: Not specified to Not applicable
    • Primary endpoint revised
    • Site details revised
    • Study arms: 0 to 2
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of our study is to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.
Trial Details
NCT Number NCT06946914
Lead Sponsor Kafrelsheikh University
Conditions
(from sponsor)		 Misoprostol, Respiratory Distress Syndrome (RDS) of Neonate, Caesarean Section
Related terms Respiratory Distress Syndrome
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov